Phase 3 multicenter randomized study of Atezolizumab versus placebo administered in combination with paclitaxel, carboplatin, and bevacizumab to patients with newly diagnosed stage 3 or 4 ovarian cancer
This study will evaluate the effect of an experimental drug in patients with newly-diagnosed ovarian, fallopian tube, and /or primary peritoneal cancer.
Those eligible to participate in this study include:
Interactive Campus Map
2500 North State Street
Jackson, MS 39216
General Information: 601-984-1000
Patient Appointments: 888-815-2005